MT 957 D-Histidine, [2,5-3H]- |
|
| C3H2HN2CH2 CH(NH2)COOH | |
| MORpure™ Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Ethanol:water (2:98) solution, 1 mCi/ml | 250 µCi (9.25 MBq) $1970 |
| > 30 Ci(1.11 TBq)/mmol | |
| NextGen V-Vial | |
| M.W. 155.15 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 2427 L-Histidine, [14C(U)]- |
|
| C3H2HN2CH2 CH(NH2)COOH | |
| MORpure™ Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
| Ethanol:water (2:98) solution, 100 μCi/ml | |
| > 250 mCi(9.25 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial | |
| M.W. 155.15 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 905 L-Histidine, [ring-2,5-3H]- Click here for Typical Certificate of Analysis |
|
| C3H2HN2CH2 CH(NH2)COOH | |
| MORpure™ Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Ethanol:water (2:98) solution, 1 mCi/ml | 250 µCi (9.25 MBq) $460 |
| > 30 Ci(1.11 TBq)/mmol | |
| NextGen V-Vial | |
| M.W. 155.15 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |